General Assembly Meeting Thursday, May 5th 10:00 – 13:00

General Assembly Meeting - 2022

A virtual (Zoom) and face-to-face meeting in Paris, France

followed by Lunch

Other Logistical information to follow nearer the time




The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.

Manganese EC Number: 231-105-1 Dossier update - CSR

A spontaneous update to the lead registration of manganese metal has been submitted to ECHA on 21st September 2021. The reason for the update was to ensure that the information on use and exposure in the CSR is representative of today’s supply chain activities and aligns with post 2010 ECHA guidance.


It recently became clear that the 2010 life cycle tree and chemical safety report (CSR) for the manganese metal registration under the REACH Regulation, did not accurately reflect the current situation. Therefore, the Manganese REACH Administration (MARA) and Exponent as the lead registrant instigated a series of interviews with relevant organisations in the manganese metal business from within the Consortium covering the entire supply chain – mining, smelting and trading.

Following on from these interviews, a questionnaire was sent to all SIEF members in order increase the information pool with regards to uses and exposure. Based on the responses from the questionnairs and the interviews,  a revised understanding of the manganese metal processes, uses and exposure patterns was obtained and used as a basis for the CSR update.

In terms of REACH registration, manganese metal also includes the alloys of manganese (i.e. ferromanganese and silicomanganese). However, other manganese compounds (e.g. manganese sulphate, manganese oxide etc.) are registered separately and hence are not considered in the CSR. Similarly, by-products of the manganese-making process, such as ferromanganese slag and silicomanganese slag, are also registered separately and do not require further assessment as part of the manganese metal lifecycle.


Uses covered: The life-cycle stages covered are as follows:

Manufacture: Manufacture of FeMn and SiMn alloy; Mn metal


Uses at industrial sites: Industrial production of steel - bulk, Industrial production of other metal articles - bulk, Industrial production of metal articles - small scale in specialist foundries

Use in the production of manganese sulphide

Industrial use in battery production

Uses by professional workers

Professional production of metal articles

Consumer uses

Consumer production of metal articles

Article service life

Service life of metal articles (industrial)

Service life of metal articles (professional)

Service life of metal articles (consumer)

Service life in welding, soldering and brazing applications by professionals

Service life of batteries by professional workers

Please note that you do not need to submit a CSR if you do not supply >10tpa in the EU market. Therefore, if you bought an LoA for Mn at >10tpa please request your updated CSR from reach@manganese.orgRegistrants receiving the CSR should check it carefully to ensure that their use of the substances falls within the scope of the exposure scenarios provided for these life-cycle stages.  They should add their  own specific details as indicated by XXXX in the CSR document.



« Back to news

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)